Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis

Age-related pharmacotherapy of attention deficit hyperactivity disorder in Slovenia in children and adolescents: A population-based study

(2017) M. Stuhec et al.   EUROPEAN PSYCHIATRY

Randomized, 6-Week, Placebo-Controlled Study of Treatment for Adult Attention-Deficit/Hyperactivity Disorder

(2016) David W. Goodman et al.   JOURNAL OF CLINICAL PSYCHIATRY

Prevalence and incidence of attention-deficit/hyperactivity disorder in Slovenian children and adolescents: a database study from a national perspective

(2015) Matej Štuhec et al.   CROATIAN MEDICAL JOURNAL

Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion

(2015) Matej Stuhec et al.   JOURNAL OF AFFECTIVE DISORDERS

Annual Research Review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents

(2015) Guilherme V. Polanczyk et al.   JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study

(2015) Søren Dalsgaard et al.   LANCET

Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients

(2015) R. Cunill et al.   PSYCHOPHARMACOLOGY

Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine

(2014) N. S. Roskell et al.   CURRENT MEDICAL RESEARCH AND OPINION

Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology

(2014) Blanca Bolea-Alamañac et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pharmacological treatment of adult ADHD in Europe

(2014) Wolfgang Retz et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan

(2014) Nagahide Takahashi et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD

(2014) Benchalak Maneeton et al.   Drug Design Development and Therapy

Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial

(2013) Michael Huss et al.   ADVANCES IN THERAPY

Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/ Hyperactivity Disorder Who Report Clinically Significant Impairment in Executive Function

(2013) Lenard A. Adler et al.   JOURNAL OF CLINICAL PSYCHIATRY

Randomized Clinical Study of a Histamine H3 Receptor Antagonist for the Treatment of Adults with Attention-Deficit Hyperactivity Disorder

(2012) Richard H. Weisler et al.   CNS DRUGS

A 9-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD

(2012) Valerie K. Arnold et al.   Journal of Attention Disorders

The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: A randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm

(2012) Joseph Biederman et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder

(2011) Xavier Castells et al.   CNS DRUGS

Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD

(2011) Joseph Biederman et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

(2011) Miguel Casas et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Understanding the Effect Size of Lisdexamfetamine Dimesylate for Treating ADHD in Children and Adults

(2010) Stephen V. Faraone   Journal of Attention Disorders

A Comparison of the Efficacy of Medications for Adult Attention-Deficit/Hyperactivity Disorder Using Meta-Analysis of Effect Sizes

(2010) Stephen V. Faraone et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Randomized, 3-Phase, 34-Week, Double-Blind, Long-Term Efficacy Study of Osmotic-Release Oral System-Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

(2010) Joseph Biederman et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Multiscale assessment of treatment efficacy in adults with ADHD: A randomized placebo-controlled, multi-centre study with extended-release methylphenidate

(2010) Wolfgang Retz et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

(2009) Michael Rösler et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis

(2009) Ágnes Mészáros et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

(2009) Alessandro Liberati et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

(2009) Lenard A. Adler et al.   JOURNAL OF CLINICAL PSYCHIATRY

Triple-Bead Mixed Amphetamine Salts (SPD465), a Novel, Enhanced Extended-Release Amphetamine Formulation for the Treatment of Adults With ADHD

(2009) Thomas J. Spencer et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

(2009) Lenard A. Adler et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of Prolonged-Release OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

(2008) Rossella Medori et al.   BIOLOGICAL PSYCHIATRY

Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder

(2008) M Koesters et al.   JOURNAL OF PSYCHOPHARMACOLOGY